第9回 日米癌合同会議
本会議は終了しました。
英文名：
9th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association
“Breakthrough in Basic and Translational Cancer Research”
会期：
2013年2月21日～2月25日
会場：
ハイアットリージェンシー、マウイ 米国
世話人：
宮園浩平（東京大学：日本癌学会側）
Tyler Jacks (Massachusetts Institute of Technology)
主催者：
日本癌学会、米国癌学会
後援：
一般社団法人 中外Oncology学術振興会議(CHAAO)
演題締切り日：
10月22日（月）
11月2日（金）まで延長致しました。
事前参加登録締切り日：
12月17日（月）
【演題登録・事前参加登録】
演題登録・事前参加登録は締め切りました
【プログラム】
プログラム詳細はこちらをクリックください。
Thursday, February 21
5:00 p.m.-6:30 p.m. Keynote Session
RNA biology and basic and translational cancer research
Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA
Targeting essential growth drivers in human cancers
Hiroyuki Mano, Jichi Medical School, Tochigi, Japan
6:30 p.m.-8:00 p.m. Opening Reception
Friday, February 22
7:00 a.m.-8:00 a.m. Breakfast/Mentoring Roundtables
8:00 a.m.-9:30 a.m. Session 1: Cancer Genomes and Tumor Evolution
Survival of the fittest: Cancer genome evolution towards adaptation
Tatsuhiro Shibata, National Cancer Center Research Institute, Tokyo, Japan
Interrogating the architecture of cancer genomes
Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
Genome-wide analyses of pediatric solid tumors
Junko Takita, University of Tokyo, Tokyo, Japan
9:30 a.m.-10:00 a.m. Break
10:00 a.m.-11:30 a.m.Session 2: Circulating Tumor Cells and Other New Diagnostic Technologies
Bioengineering and clinical applications of circulating tumor cell chips
Shyamala Maheswaran, Massachusetts General Hospital, Charlestown, MA, USA
PLS3 expression in circulating blood is a good marker for colon cancer recurrence
Masaki Mori, Osaka University, Osaka, Japan
The clinical application of circulating tumor DNA
Luis A. Diaz, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
11:30 a.m.-3:30 p.m.Free Time
3:30 p.m.-5:00 p.m. Session 3: Noncoding RNAs
Senescence-associated microRNAs, a novel approach to tumor suppression
Hidetoshi Tahara, Hiroshima University, Hiroshima, Japan
microRNA reprogramming in cancer: Mechanisms and consequences
Joshua Mendell, UT Southwestern Medical Center, Dallas, TX, USA
Linking RNA to human health and disease
John L. Rinn, Harvard University, Cambridge, MA, USA
5:00 p.m.-7:00 p.m. Poster Session A
Saturday, February 23
7:00 a.m.-8:00 a.m. Breakfast/Mentoring Roundtables
8:00 a.m.-10:00 a.m. Session 4: DNA Damage Response
DNA damage response and cellular senescence in cancer
Eiji Hara, Japanese Foundation for Cancer Research, Tokyo, Japan
Harnessing genetic dependencies in cancer therapy
Alan Ashworth, Institute of Cancer Research, London, United Kingdom
Complex regulation of homologous recombination by E3 ligases
Shinichiro Nakada, Osaka University, Osaka, Japan
10:00 a.m.-10:30 a.m. Break
10:30 a.m.-12:00 a.m. Session 5: Epigenetics and Cancer Cell States
Epigenetic plasticity and its clinical implications in human neoplasia
Yutaka Kondo, Aichi Cancer Center, Nagoya, Japan
The regulation of melanoma metastasis
Sean J. Morrison, UT Southwestern Medical Center, Dallas, TX, USA
Dysregulation of noncoding RNA genes and its clinical application
Hiromu Suzuki, Sapporo Medical University, Sapporo, Japan
12:00 a.m.-3:30 p.m.Free Time
3:30 p.m.-5:00 p.m. Session 6: Cancer Progression and Metastasis
Molecular characterization of lung cancer progression
Tyler Jacks, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA
Significance of hypoxia-inducible factor in cancer progression and metastasis
Shinae Kondoh, Tokyo Institute of Technology, Tokyo, Japan
The systemic environment as an important determinant of malignancy
Sandra S. McAllister, Brigham and Women’s Hospital, Boston, MA, USA
5:00 p.m.-7:00 p.m. Poster Session B
Sunday, February 24
7:00 a.m.-8:00 a.m. Breakfast/Mentoring Roundtables
8:00 a.m.-9:30 a.m. Session 7: Tumor Microenvironment
Molecular control of tumor vessel destabilization
Gou Young Koh, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
Chronic inflammation and cancer: Translating basic science to the clinic
Lisa M. Coussens, Oregon Health & Science University’s Knight Cancer Institute, Portland, OR, USA
Mint3 promotes tumor malignancy in cancer and stromal cells
Takeharu Sakamoto, University of Tokyo, Institute of Medical Science, Tokyo, Japan
9:30 a.m.-10:00 a.m. Break
10:00 a.m.-11:30 a.m. Session 8: Cancer Immunology and Immunotherapy
Immune checkpoint blockade in cancer therapy: New insights and opportunities
James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Impact of innate and acquired immune responses in adult T-cell leukemia
Mari Kannagi, Tokyo Medical and Dental University, Tokyo, Japan
microRNAs and myeloid-derived suppressor cells in tumor immune escape
Qingqing Wang, Zhejiang University School of Medicine, Hangzhou, China
11:30 a.m.-3:30 p.m. Free Time
3:30 p.m.-5:00 p.m. Session 9: Preclinical Models
GEM models in translational research
Lynda Chin, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Novel strategies for targeting cancer stem cells
Hideyuki Saya, Keio University, Tokyo, Japan
Contributions of the tumor microenvironment to chemoresistance
Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
5:00 p.m.-7:00 p.m. Poster Session C
Monday, February 25
7:00 a.m.-8:00 a.m. Breakfast/Mentoring Roundtables
8:00 a.m.-9:30 a.m. Session 10: Signaling and Systems Biology
Targeted sequencing of Asian cancer phenotypes
Patrick Tan, Duke-NUS Graduate Medical School Singapore, Singapore
A systems approach to understanding and predicting therapeutic response
Joe W. Gray, Oregon Health & Science University’s Knight Cancer Institute, Portland, OR, USA
Statistical gene network analysis for understanding cancer heterogeneity
Seiya Imoto, University of Tokyo, Institute of Medical Science, Tokyo, Japan
9:30 a.m.-10:00 a.m. Break
10:00 a.m.-11:30 a.m. Session 11: Cancer Prevention
Energy balance and inflammation in cancer prevention and prognosis
Cornelia M. Ulrich, German Cancer Research Center, Heidelberg, Germany GWAS
revealed the roles of gene-environmental interaction in carcinogenesis
Koichi Matsuda, University of Tokyo, Institute of Medical Science, Tokyo, Japan
Targeting the DNA repair network as a novel approach for cancer prevention
Guang Peng, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
11:30 a.m.-3:30 p.m. Free Time
3:30 p.m.-4:30 p.m. Session 12: Targeted Therapies and Resistance
Title to be announce
Jeffrey E. Settleman, Genentech, Inc., South San Francisco, CA, USA
TTF-1: A double-edged sword in lung adenocarcinoma
Takashi Takahashi, Nagoya University, Nagoya, Japan
Biological mechanisms of resistance to targeted therapies
Katerina A. Politi, Yale Cancer Center, New Haven, CT, USA
4:30 p.m.-6:30 p.m. Poster Session D
7:00 p.m.-10:00 p.m. Closing Reception and Banquet
【旅行プラン】
旅行プランは締め切りました
